China Cord Blood Completes Secondary Offering on NYSE
publication date: Nov 20, 2009
China Cord Blood Corporation listed its ordinary shares on the New York Stock Exchange and, at the same time, completed a secondary offering. The company placed 3.3 million shares at a price of $6.05 for gross proceeds of $20 million. China allows one cord blood collection license for each major area, and China Cord Blood owns the licenses for Beijing and Guangdong. More details...
Stock Symbol: (NYSE: CO)
Sorry... this feature or article is only available to subscribers.